Lupin launches Molnupiravir beneath the brand name Molnulup

Lupin launches Molnupiravir beneath the brand name Molnulup

by admin- Friday, January 7th, 2022 03:38:22 PM

Global pharma most important Lupin introduced the launch of Molnupiravir in India underneath the logo call Molnulup. This drug has been given emergency use authorization by way of the Drug Controller General of India (DCGI) for remedy of grownup patients with Covid19, with SpO2 > ninety three%, and those who have a high hazard of progression of the sickness including hospitalization.

Internationally, Molnupiravir is an oral antiviral that has been accredited by the United Kingdom Medicines and Healthcare merchandise Regulatory Agency (MHRA) and the U.S.Food and Drug Administration (FDA) for the treatment of moderate-to-mild instances of COVID-19 in adults.

News Updates